A Director at Luminex (NASDAQ: LMNX) is Buying Shares

By Carrie Williams

Yesterday, a Director at Luminex (LMNXResearch Report), Walter Loewenbaum, bought shares of LMNX for $1.47M.

This is Loewenbaum’s first Buy trade following 5 Sell transactions. Following this transaction Walter Loewenbaum’s holding in the company was increased by 4.21% to a total of $37.82 million.

See today’s analyst top recommended stocks >>

Based on Luminex’s latest earnings report for the quarter ending September 30, the company posted quarterly revenue of $78.67 million and GAAP net loss of $5.22 million. In comparison, last year the company earned revenue of $72.45 million and had a net profit of $1.71 million. The company has a one-year high of $30.16 and a one-year low of $17.35. Currently, Luminex has an average volume of 251.54K.

Walter Loewenbaum’s trades have generated a -11.7% average return based on past transactions. DailyInsider proprietary algorithm detects trades by the most influential insiders and selects attractive trading opportunities daily. To subscribe to the DailyInsider visit this page.

TipRanks has tracked 36,000 company insiders and found that a few of them are better than others when it comes to timing their transactions. See which 3 stocks are most likely to make moves following their insider activities.

Luminex Corp. develops, manufactures and markets proprietary biological testing technologies and products with applications throughout the life sciences and diagnostics industries. The company was founded by Mark B. Chandler and Van S. Chandler in May 1995 and is headquartered in Austin, TX.